IL17A and early-onset autosomal dominant Alzheimer disease: Potential pathways were also predicted, including those involved in lipid metabolism, atherosclerosis, PI3K‐Akt signaling, MAPK, IL‐17, TNF, neurotrophin signaling, apoptosis, Alzheimer's disease, and other neurodegenerative diseases.